HIGH CONTENT SCREENING MARKET ANALYSIS

High Content Screening Market, By Product Type (Cell Imaging and Analysis Equipment, Consumables, HCS Software, HCS Services), By Application (Primary Screening, Target Identification & Validation, Toxicity Studies, Compound Profiling, Others), By End User (Pharmaceutical Organizations, Biotechnology Organizations, Research Institutes, Independent CRO, Government Organizations, Others), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018 - 2030

Published In : Jun 2023
Code : CMI3487
Pages :167
Formats :
Excel and PDF
Industry : Clinical Diagnostic

Regional Analysis

Global High Content Screening Market- Regional Analysis

North America region held dominant position in the global high content screening (HCS) market in 2022 accounting for 43.7% share in terms of value, followed by Europe. According to data provided by Cente For Disease Control and Prevention on 8 May 2023, six out of ten Americans are now dealing with a chronic illness such as , heart disease, or every year.Due to important growth drivers such as increasing chronic disorders, North America held the highest share of the market.

European market trails with 20.1 % market share. According to data published by Eurostat on 17 April 2023, nearly one-fifth (18.2%) of healthcare spending in the EU in 2020 was for medical supplies, while more than half (53.1%) went towards curative and rehabilitative care. Eurostat is the statistical office of the European Union, responsible for publishing Europe-wide statistics and indicators that enable comparisons between countries and regions. By spending nearly two-fifths (37.4%) of total healthcare spending in the EU in 2020, hospitals were the top payers for healthcare services. This increase in healthcare infrastructure proves to be a major driver for a high European HCS market. The demand for clinical research is increasing again in the Asia Pacific region due to the lift in COVID-19 bans. State governments in India and China are adopting various research strategies for testing purposes. South Korea, Japan, and Singapore effectively tracked the COVID-19 virus through robust tracking systems , thus increasing a demand for HCS systems in the region.

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC Countries, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa